Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals





Globe NewsWire News Distribution Service


NEW YORK, May 31, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against POET Technologies Inc. (NASDAQ: POET) and certain of its officers.


Posted: 2026-05-31 16:00:00

Get Full News Story On GlobeNewsWire Press Release Service




More News From This Category
Press Release: CAPHRA Calls for Full Stakeholder Inclusion in Tobacco Control Policy
Sun, 31 May 2026 19:07:39 +0000

MANILA, Philippines, June 01, 2026 (GLOBE NEWSWIRE) -- The Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA) has released a position paper calling on policymakers across the Asia Pacific region to adopt a formal inclusion standard for all significant public health and tobacco control policy work. The paper argues that policies designed without meaningful input…

Read More ...


Press Release: Why AI Visibility Operating Systems Are Replacing Fragmented Marketing Strategies
Sun, 31 May 2026 13:07:38 +0000

NEW YORK, NY, May 31, 2026 (GLOBE NEWSWIRE) -- NEWMEDIA.COM today released new analysis examining why many organizations are moving away from fragmented digital marketing structures and toward integrated AI Visibility Operating Systems designed to coordinate discoverability, authority, conversion optimization, analytics infrastructure, and AI-era search visibility into unified growth systems.

Read More ...


Press Release: Nokia Corporation - Managers' transactions (Hanrahan)
Sun, 31 May 2026 10:07:42 +0000

Nokia CorporationManagers’ transactions31 May 2026 at 13:00 EEST Nokia Corporation - Managers' transactions (Hanrahan) Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Hanrahan, VictoriaPosition: Other senior manager

Read More ...


Press Release: Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
Sun, 31 May 2026 07:07:53 +0000

Basel, May 31, 2026 – Novartis today announced results showing consistent radiographic progression-free survival (rPFS) improvement across key subgroups with Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) plus standard of care (SoC; androgen receptor pathway inhibitor [ARPI] + androgen deprivation therapy [ADT]) compared to SoC alone in PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC). These PSMAddition data…

Read More ...


Related Bing News Results





















Blow Us A Whistle


Related Product Search/Búsqueda de productos relacionados

Amazon Logo

Visit Our New Print-On-Demand Stores On Printify and Zazzle
Printify Zazzle